fashion -WSS

fashion

author：comprehensive 2025-09-28 21:11:48 - browse：2

Layoff concept illustration of empty desks and people walking away. — Adobe

Dewpoint Therapeutics, the buzziest startup trying to tackle a new field of biology called biomolecular condensates, laid off 15% of its staff on Tuesday and acknowledged that a pair of collaboration deals with pharma companies had fallen apart.

The downsizing is temporary, CEO Ameet Nathwani told STAT. The company needed to hire new employees with expertise to help move the company’s first drugs into clinical trials and expand its AI capabilities. And with funding for early-stage biotechs still sparse, leadership opted to cut some positions and use the savings to fill new ones over the coming months. Roughly 20 positions were cut.

“We talked to investors right now [about raising more money], and they think that the environment for a preclinical company — it’s not even worth having that discussion,” Nathwani said.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New air purifier tech could be key to improving indoor air quality
Next article： Reframing the conversation around gain

WSS

New chart reveals military’s vast involvement in Operation Warp Speed

Liver decline slowed by off

Grand jury probing Trump's efforts to overturn 2020 election did not meet Friday: Sources

EMA weighs against approval for Mirati's lung cancer drug

Readout Newsletter: H5N1 bird flu vaccine, Cytokinetics, Gilead

As a primary care physician, here's how I hope to partner with AI

entertainment

fashion

focus

Hepatitis C has a cure — but many Americans still lack access to it

Grand jury probing Trump's efforts to overturn 2020 election did not meet Friday: Sources

Guidelines to prevent youth baseball injuries need more muscle

It's time to take a new tack for treating Alzheimer's

Walensky prepares to leave CDC — and Congress — behind

A new deal aims to ramp up use of AI in rehab care decisions

Alkermes shareholders re

Biden, Billy Joel, Elton John lead tributes for Tony Bennett after singer's death at 96

Heart attack and stroke risk calculators need revising

Reports of telehealth's death have been greatly exaggerated

focus

How Brent Saunders' Allergan experiment failed

Reframing the conversation around gain

What is artificial intelligence? Experts weigh in

Bird flu surveillance in wastewater gets boost from consortium

Fentanyl is making it harder to start addiction treatment

The Readout: Biogen, Guardant, AstraZeneca, H5N1 vaccine

hotspot

hotspot

focus

leisure time